Erratum

Article Outline

• Copyright

An asterisk was misplaced in Table 5 on page S21 of the article entitled “Decitabine Dosing Schedules” by Hagop M. Kantarjian and Jean-Pierre J. Issa, which appeared in Seminars in Hematology in the July 2005 supplement 2 (Vol 42, No 3, Suppl 2). The corrected table appears below.

Table 5. Clinical Responses of Decitabine in the Dose Optimization Trial

Dosing Schedule	No. CR/Total (%)
20 mg/m2 IV × 5 days	15/32(47)⁎
20 mg/m2 SC × 5 days	4/14(29)
10 mg/m2 IV × 10 days	4/17(24)
Total	23/63(37)

Abbreviations: CR, complete response; IV, intravenous; SC, subcutaneous.

Data from O’Brien et al.¹²